Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Ordinary Shares, nominal value EUR0.05 per share
-
Shares outstanding
-
95,490,450
-
Total 13F shares
-
13,222,126
-
Share change
-
+74,867
-
Total reported value
-
$226,376,965
-
Price per share
-
$17.12
-
Number of holders
-
56
-
Value change
-
+$2,249,267
-
Number of buys
-
24
-
Number of sells
-
28
Institutional Holders of Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) as of Q4 2019
As of 31 Dec 2019 Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) had 56 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 13,222,126 shares of stock of the company.
Largest 10 holders included FMR LLC, ARK Investment Management LLC, Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Holdings, Inc., Capital International Investors, Capital World Investors, MORGAN STANLEY, ADAGE CAPITAL PARTNERS GP, L.L.C., CITADEL ADVISORS LLC, and CREDIT SUISSE AG/.
This table shows 56 institutional shareholders of the security as of 31 Dec 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.